18 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
12 Sep 22
Report of Foreign Private Issuer
8:02am
and further our understanding of its safety profile and anti-cancer activity. Successfully achieving these goals would represent a key milestone
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
of the Company during the period of employment
The contribution of the executive officer in the achievement by the Company of its goals and earn … executives who are capable of leading the Company to long-term business success, achieving the Company’s goals and meeting the challenges it faces
20-F/A
rg4go09k spsif06
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
vu88lvk64p
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
muy g3cl77
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
20-F
hteszrps
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
qw7es9i1fnoeb
10 Feb 15
Notice of Extraordinary General Meeting of Shareholders
12:00am
424B4
l5d4hf fimiu1g9i
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
leuf2aixsso
8 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-3.2
1tvlzz 3c
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next